1 / 29

Ikushi Onozaki WHO/STB/TBS Global Task Force on TB Impact Measurement

The role of prevalence surveys in measuring the burden of TB, progress in TB control and improving early case detection. Ikushi Onozaki WHO/STB/TBS Global Task Force on TB Impact Measurement. DEWG meeting, Oct 13-14 2009, Geneva. Content. Background Task Force recommendations

paula-carr
Télécharger la présentation

Ikushi Onozaki WHO/STB/TBS Global Task Force on TB Impact Measurement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The role of prevalence surveys in measuring the burden of TB, progress in TB control and improving early case detection Ikushi Onozaki WHO/STB/TBS Global Task Force on TB Impact Measurement DEWG meeting, Oct 13-14 2009, Geneva

  2. Content • Background • Task Force recommendations • What is needed to implement a survey and what can surveys tell us? • Current status of survey implementation • Next steps

  3. Background • TB prevalence is an MDG indicator that can be directly measured in HBCs • Estimation of TB burden using tuberculin surveys no longer applicable in most settings • Funding is available for surveys, and governments and international agencies recognize importance of measuring impact

  4. Task Force recommendations

  5. Countries where surveys are recommended 21 global focus countries 36 additional countries that met basic criteria

  6. How should surveys be implemented? Follow the guidelines!

  7. Recommended screening strategy Do smear and culture at least for with TB symptoms and/or abnormal chest X-ray

  8. What is needed to implement a survey?

  9. ( WHO headquarters, March 2008)

  10. What is required for a survey? • Sample size : 30,000- 60,000 • Cluster size: 500-1,000 • 12-15 staff per field team for 6–10 months, 3-4 team operation • Costs ~ US$1 million in Asia, US$2 million in Africa Capital investment (CXR, Lab, Cars), Human Resource (Salaries), Survey Operation (Field and Central), Pre & Post survey events, technical assistance

  11. Go to the community

  12. Survey day Transport people to X-ray site

  13. Individual interview by trained health professional from central unit • TB related symptoms • TB history • Possible treatment • Consultation Places • Risk factors

  14. Develop and read images on the SpotQuality Direct X-ray is Available in Villages that contributed to high participation rates and 100% sputum collection from suspects

  15. Prevalence Survey in Viet Nam Digital technology was introduced for the first time to National Scale TB survey

  16. Lab work Smear Microscopy Direct Smear, ZN LED-FL Collect, Store, Transport and Put in Culture within 5 days

  17. What can be learned from a survey?

  18. A carefully designed survey can tell you lots more than TB prevalence • Changes in TB burden and re-estimation of burden • Performance of strategies for screening of TB suspects • Health-seeking behaviour of TB patients and individuals reporting chest symptoms • Where and why are cases missed by the NTP e.g. access to care, role of private sector • Risk factors

  19. Re-estimation of TB Burden • Prevalence of Sm+ TB in Cambodia, 2002, was half of previous estimate and previous study results • Prevalence of S+ in Yangon, Myanmar, nearly 3 times previous national estimate -> National Survey • Prevalence of S+ in Viet Nam, 2007, was 60% more than previous estimate •  Prevalence Surveys can help to revise and improve estimates of disease burden and CDR

  20. Strategies for screening TB suspects 40-60% of confirmed cases in surveys do not have chronic cough NTP Cambodia. National TB Prevalence Survey Report, 2002. 2005, ** H Ayles et al. Plos one May 2009. e 5602, *** NTP Viet Nam. Presented in UNION APR Conference, Beijing, Sept 2009

  21. Smear microscopy alone misses >50% of bacteriologically-confirmed TB *Africa 5 sub-national surveys average

  22. Where are cases being missed? Yangon survey, 2006: 1/3 of TB patients being treated by GPs 33 in NTP: around 130/100,000 = 260/100,000/year

  23. Current status of survey implementation

  24. Good progress in Asia

  25. No survey in Africa started yet – urgent action required!! HBC Other countries preparing: Ghana, Malawi, Mali, Rwanda, Togo, Zambia,

  26. Next steps

  27. Workshop on prevalence surveys in 12 African countries, 15-16 October 2009 • Identification of bottlenecks holding up survey implementation • Lessons from Asia • How to solve the bottlenecks • Role of Task Force partners in providing technical assistance to countries

More Related